Acelyrin shares decline after programming error disclosure | Pacific Coast Business Times

Acelyrin's headquarters in Agoura Hills. (courtesy photo) Conejo Valley-based Acelyrin saw shares plummet more than 30% on Nov. 28 after the biotechnology startup announced an error in one of its trials for its main treatment. Acelyrin, which is a part of Westlake Village BioPartners investing portfolio, disclosed there was a programming error in a drug

Related Keywords

Sweden , Swedish , Los Angeles , Shao Lee Lin , , Jorge Mercado Wednesday , Valley Based Acelyrin , Westlake Village Biopartners , Swedish Based Affibody , Conejo Valley , Ventura County , Lee Lin , Agoura Hills , Los Angeles County , Thousand Oaks , Earnings , Health Care Amp Life Science , Latest News , Top Stories , Top Story , Tri County Economy , Tri County Public Companies ,